Rchr
J-GLOBAL ID:201801020234975136   Update date: Jun. 21, 2024

Adachi Yu

Adachi Yu
Affiliation and department:
Papers (34):
  • Keisuke Tonouchi, Yu Adachi, Tateki Suzuki, Daisuke Kuroda, Ayae Nishiyama, Kohei Yumoto, Haruko Takeyama, Tadaki Suzuki, Takao Hashiguchi, Yoshimasa Takahashi. Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope. PLOS Pathogens. 2023. 19. 8. e1011554-e1011554
  • Saya Moriyama, Yuki Anraku, Shunta Taminishi, Yu Adachi, Daisuke Kuroda, Shunsuke Kita, Yusuke Higuchi, Yuhei Kirita, Ryutaro Kotaki, Keisuke Tonouchi, et al. Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants. Nature communications. 2023. 14. 1. 4198-4198
  • Mizuki Fujisawa, Yu Adachi, Taishi Onodera, Nozomi Shiwa-Sudo, Naoko Iwata-Yoshikawa, Noriyo Nagata, Tadaki Suzuki, Shinji Takeoka, Yoshimasa Takahashi. High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection. Biochemical and biophysical research communications. 2023. 673. 114-120
  • Taishi Onodera, Nicolas Sax, Takashi Sato, Yu Adachi, Ryutaro Kotaki, Takeshi Inoue, Ryo Shinnakasu, Takayuki Nakagawa, Shuetsu Fukushi, Tommy Terooatea, et al. CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes. Science advances. 2023. 9. 24. eadf0661
  • Ayae Nishiyama, Yu Adachi, Keisuke Tonouchi, Saya Moriyama, Lin Sun, Masamitsu Aoki, Hideki Asanuma, Masayuki Shirakura, Akihisa Fukushima, Takuya Yamamoto, et al. Post-fusion influenza vaccine adjuvanted with SA-2 confers heterologous protection via Th1-polarized, non-neutralizing antibody responses. Vaccine. 2023
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page